In Vitro Selection of MRSA Strains Resistant to Some New Fluoroquinolone Antibiotics and Characterization of their Resistance Mechanisms
![]() |
Yoon, Eun-Jeong
(College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Kim, Hyun-Jee (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) Lee, Chun-Yeong (Department of Life Science, University of Seoul) Choi, Eung-Chil (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) Shim, Mi-Ja (Department of Life Science, University of Seoul) |
1 | Acar, J. F. and Francoual, S. : The clinical problems of bacterial resistance to the new quinolones. J. Antimicrob. Chemother. 26 Suppl B, 207 (1990) DOI PUBMED |
2 | Hamett, N., Brown, S. and Krishnan, C. : Emergence of quinolone resistance among clinical isolate of methicillinresistant Staphylococcus aureus in Ontario, Canada. Antimicrob. Agents Chemother. 35, 1911 (1991) DOI PUBMED ScienceOn |
3 | Kosowska-Shick, K., Credito, K., Pankuch, G. A., Lin, Gengrong., Bozdogzn, B., McGhee, P., Dewasse, B., Choi, D. R., Ryu, J. M. and Appelbaum, P. C. : Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents. Antimicrob. Agents Chemother. 50, 2064 (2006) DOI ScienceOn |
4 | Kim, M. J., Yun, H. J., Kang, J. W., Kim, S., Kwak, J. H. and Choi, E. C. : In vitro development of resistance to a novel fluoroquinolone, DW286, in methicillin-resistant Staphylococcus aureus clinical isolates. J. Antimicrob. Chemother. 51, 1011 (2003) DOI ScienceOn |
5 | Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M. and Nakamura, S. : Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother. 35, 1647 (1991) DOI PUBMED ScienceOn |
6 | Piddock, L. J. : Mechanisms of fluoroquinolone resistance: and update 1994-1998. Drugs 58 Suppl 2, 11 (1999) PUBMED |
7 | Aeschlimann ,J. R., Dresser, L. D., Kaatz, G. W. and Rybak, M. J. : Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 43, 335 (1999) PUBMED |
8 | Daum, R. S. and Seal, J. B. : Evolving antimicrobial chemotherapy for Staphylococcus aureus infection: our backs to the wall. Crit. Care Med. 29 Suppl 4, N92 (2001) DOI ScienceOn |
9 | Clinical and Laboratory Standards Institute (CLSI), Performance standards for antimicrobial susceptibility testing; 15th informational Supplement. Document M100-S15, CLSI, Wayne, PA (2005) |
10 | Kwon, A. R., Min, Y. H., Ryu, J. M., Choi, D. R., Shim, M. J. and Choi, E. C. : In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent. J. Antimicrob. Chemother. 58, 684 (2006) DOI ScienceOn |
11 | Weigel, L. M., Anderson, G. J., Facklam, R. R. and Tenover, F. C. : Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45, 3517 (2001) DOI ScienceOn |
12 | Ince, D. and Hooper, D. C. : Mechanisms and frequency of resistance to premafloxacin in Staphylococcus aureus: novel mutations suggest novel drug-target interactions. Antimicrob. Agents Chemother. 44, 3344 (2000) DOI ScienceOn |
13 | Tanaka, M., Wang, T., Onodera, Y., Uchida, Y. and Sato, K. : Mechanisms of quinolone resistance in Staphylococcus aureus. J. Infect. Chemother. 6, 131 (2000) DOI ScienceOn |
14 | Piddock, L. J. V. : Newer fluoroquinolones and Gram positive bacteria. ASM News 59, 603 (1993) |
15 | Chanbers, H. F. : The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis. 7, 178 (2001) DOI PUBMED ScienceOn |
16 | Park, H. S., Kim, H. J., Seol, M. J., Choi, D. R., Choi, E. C. and Kwak, J. H. : In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone Antimicrob. Agents Chemother. 50, 2261 (2006) DOI ScienceOn |
![]() |